Attached files

file filename
10-Q - FORM 10-Q - Enterologics, Inc.elgo_10q.htm
EX-32.2 - CERTIFICATION - Enterologics, Inc.elgo_ex322.htm
EX-32.1 - CERTIFICATION - Enterologics, Inc.elgo_ex321.htm
EX-31.2 - CERTIFICATION - Enterologics, Inc.elgo_ex312.htm
EX-10.27 - PROMISSORY NOTE - Enterologics, Inc.elgo_ex1027.htm
EX-10.26 - EXTENSION TO LETTER AGREEMENT - Enterologics, Inc.elgo_ex1026.htm
EX-10.25 - PROMISSORY NOTE - Enterologics, Inc.elgo_ex1025.htm
EXCEL - IDEA: XBRL DOCUMENT - Enterologics, Inc.Financial_Report.xls
EX-31.1 - CERTIFICATION - Enterologics, Inc.elgo_ex311.htm
EXHIBIT 10.28
 

 
As of  October 15, 2012

Victor Bronshtein, Ph.D.
Universal Stabilization Technologies, Inc.
4050 Sorrento Valley Blvd., Suite L
San Diego, CA 92121
Subject:  Further Extension to LOI dated January 7, 2011
 
Dear Victor:
 
The following is quoted from the executed LOI:

·  
No later than May 15, 2011, the Licensee and the Licensor will sign and begin executing a mutually agreeable one-year Pilot Development Project.
·  
Starting on the earlier of (i) May 15, 2011, or (ii) the first day after signing the Pilot Development Project, the Licensee will be obligated to pay the Licensor or at least CA$8333.33 per month for the work performed by Licensor under the Pilot Development Project. The Licensee and the Licensor will negotiate in good faith the goals, objectives and work product of the Pilot Development Project and the actual amount of the such monthly payment, which may be in excess of CA$8,333.33, depending on the scope of the work requested by Licensee.
·  
The Option Period for the exclusive option to enter into the License Agreement on the License Terms described below will expire on the earlier of (i) May 15, 2012 or (ii) the date the Licensee ceases to make monthly payments to the Licensor for the Pilot Development Project.

This  Agreement was previously extended on  May 4th, 2012  and on August  15th, 2012 For good and valuable consideration the parties agree that the terms of this LOI is now extended to December  15, 2012. Monthly payments during the extension period will continue at the same rate. All other terms and conditions remain the same.
 
/s/ Victor Bronshtein, PhD       /s/ Bob Hoerr  
Victor Bronshtein, PhD    
 
Bob Hoerr  
President and Chief Scientific Officer    President & CEO  
Universal Stabilization Technologies, Inc.    Enterologics, Inc.